Log in
Enquire now
‌

Extended Delivery of Bupivacaine Study in Herniorrhaphy

OverviewStructured DataIssuesContributors
Is a
‌
Clinical study
0
Allocation Type
Randomized
0
Health Conditions in Trial
‌
Analgesia
0
Intervention Model
Parallel Assignment
0
Intervention Name
Bupivacaine liposome injectable suspension
0
Bupivacaine HCl without epinephrine via continuous infusion
0
Interventional Trial Phase
Phase 4
0
Interventional Trial Purpose
Prevention
0
Intervention Type
Drug
0
Last Updated
September 26, 2019
0
Masking Type
None (Open Label)
0
Primary Completion Date
September 3, 2018
0
Trial Recruitment Size
32
0
Trial Sponsor
Heron Therapeutics
Heron Therapeutics
0
Clinical Trial Start Date
July 2, 2018
0
Study Completion Date
October 26, 2018
0
Clinical Trial Study Type
Interventional
0
NCT Number
NCT04102267
0
Official Name
A Randomized, Phase 4 Study of the Efficacy, Safety, and Pharmacokinetics of Bupivacaine Administered as Liposomal Bupivacaine or Continuous Infusion Via Elastomeric Pump Following Unilateral Open Inguinal Herniorrhaphy
0
Official Website
clinicaltrials.gov/study...102267
0

Find more entities like Extended Delivery of Bupivacaine Study in Herniorrhaphy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.